ReP USP - Resultado da busca

Artigo de periodico
Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: a case-control study (2020)
Charruf, Amir Zeide; Ramos, Marcus Fernando Kodama Pertille; Pereira, Marina Alessandra; Dias, Andre Roncon; Castria, Tiago Biachi de; Zilberstein, Bruno ; Cecconello, Ivan ; Ribeiro Junior, Ulysses
Source: Journal of surgical oncology. Unidade: FM
Subjects: NEOPLASIAS GÁSTRICAS, ESTUDOS RETROSPECTIVOS, METÁSTASE LINFÁTICA, TEMPO DE INTERNAÇÃO, GASTRECTOMIA, QUIMIOTERAPIA, ADENOCARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHARRUF, Amir Zeide et al. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: a case-control study. Journal of surgical oncology, v. 121, n. 5, p. 833-839, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25839. Acesso em: 18 nov. 2024.
APA
Charruf, A. Z., Ramos, M. F. K. P., Pereira, M. A., Dias, A. R., Castria, T. B. de, Zilberstein, B., et al. (2020). Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: a case-control study. Journal of surgical oncology, 121( 5), 833-839. doi:10.1002/jso.25839
NLM
Charruf AZ, Ramos MFKP, Pereira MA, Dias AR, Castria TB de, Zilberstein B, Cecconello I, Ribeiro Junior U. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: a case-control study [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 833-839.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25839
Vancouver
Charruf AZ, Ramos MFKP, Pereira MA, Dias AR, Castria TB de, Zilberstein B, Cecconello I, Ribeiro Junior U. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: a case-control study [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 833-839.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25839
Artigo de periodico
Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer (2020)
Pereira, Marina Alessandra; Ramos, Marcus Fernando Kodama Pertille; Dias, Andre Roncon; Cardili, Leonardo; Ribeiro, Renan Ribeiro e; Charruf, Amir Zeide; Castria, Tiago Biachi de; Zilberstein, Bruno ; Cecconello, Ivan ; Alves, Venancio Avancini Ferreira ; Ribeiro Junior, Ulysses ; Mello, Evandro Sobroza de
Source: Journal of surgical oncology. Unidade: FM
Subjects: NEOPLASIAS GÁSTRICAS, ESTUDOS RETROSPECTIVOS, PROGNÓSTICO, LINFONODOS, GASTRECTOMIA, QUIMIOTERAPIA, ADENOCARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marina Alessandra et al. Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer. Journal of surgical oncology, v. 121, n. 5, p. 795-803, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25785. Acesso em: 18 nov. 2024.
APA
Pereira, M. A., Ramos, M. F. K. P., Dias, A. R., Cardili, L., Ribeiro, R. R. e, Charruf, A. Z., et al. (2020). Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer. Journal of surgical oncology, 121( 5), 795-803. doi:10.1002/jso.25785
NLM
Pereira MA, Ramos MFKP, Dias AR, Cardili L, Ribeiro RR e, Charruf AZ, Castria TB de, Zilberstein B, Cecconello I, Alves VAF, Ribeiro Junior U, Mello ES de. Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 795-803.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25785
Vancouver
Pereira MA, Ramos MFKP, Dias AR, Cardili L, Ribeiro RR e, Charruf AZ, Castria TB de, Zilberstein B, Cecconello I, Alves VAF, Ribeiro Junior U, Mello ES de. Lymph node regression after neoadjuvant chemotherapy: a predictor of survival in gastric cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 795-803.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25785
Artigo de periodico
Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? (2020)
Ramos, Marcus F. K. P; Pereira, Marina A; Amorim, Larissa C; Mello, Evandro S. de; Faraj, Sheila F; Ribeiro Junior, Ulysses ; Hoff, Paulo Marcelo Gehm ; Cecconello, Ivan ; Castria, Tiago B. de
Source: Journal of surgical oncology. Unidade: FM
Subjects: ADENOCARCINOMA, ANTÍGENOS, HERPES SIMPLES, ESTUDOS RETROSPECTIVOS, NEOPLASIAS GÁSTRICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Marcus F. K. P et al. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?. Journal of surgical oncology, v. 121, n. 5, p. 804-813, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25792. Acesso em: 18 nov. 2024.
APA
Ramos, M. F. K. P., Pereira, M. A., Amorim, L. C., Mello, E. S. de, Faraj, S. F., Ribeiro Junior, U., et al. (2020). Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? Journal of surgical oncology, 121( 5), 804-813. doi:10.1002/jso.25792
NLM
Ramos MFKP, Pereira MA, Amorim LC, Mello ES de, Faraj SF, Ribeiro Junior U, Hoff PMG, Cecconello I, Castria TB de. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 804-813.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25792
Vancouver
Ramos MFKP, Pereira MA, Amorim LC, Mello ES de, Faraj SF, Ribeiro Junior U, Hoff PMG, Cecconello I, Castria TB de. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype? [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 804-813.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25792
Artigo de periodico
The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer (2020)
Tustumi, Francisco; Takeda, Flavio Roberto; Viyuela, Mateus Silva; Cruz Junior, Jurandir Batista da; Brandao, Antonio Adolfo Guerra Soares; Sallum, Rubens Antonio Aissar; Ribeiro Junior, Ulysses ; Cecconello, Ivan
Source: Journal of surgical oncology. Unidade: FM
Subjects: ESTUDOS RETROSPECTIVOS, PROGNÓSTICO, NEUTRÓFILOS, HEMOGLOBINAS, TESTES HEMATOLÓGICOS, NEOPLASIAS ESOFÁGICAS, ESTUDOS DE COORTES, ADENOCARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TUSTUMI, Francisco et al. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. Journal of surgical oncology, v. 121, n. 5, p. 784-794, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25778. Acesso em: 18 nov. 2024.
APA
Tustumi, F., Takeda, F. R., Viyuela, M. S., Cruz Junior, J. B. da, Brandao, A. A. G. S., Sallum, R. A. A., et al. (2020). The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. Journal of surgical oncology, 121( 5), 784-794. doi:10.1002/jso.25778
NLM
Tustumi F, Takeda FR, Viyuela MS, Cruz Junior JB da, Brandao AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 784-794.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25778
Vancouver
Tustumi F, Takeda FR, Viyuela MS, Cruz Junior JB da, Brandao AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 784-794.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25778
Artigo de periodico
Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma (2020)
Dias, Andre R; Pereira, Marina A; Oliveira, Rodrigo J; Ramos, Marcus F. K. P; Szor, Daniel J; Ribeiro Junior, Ulysses ; Zilberstein, Bruno ; Cecconello, Ivan
Source: Journal of surgical oncology. Unidade: FM
Subjects: ADENOCARCINOMA, NEOPLASIAS GÁSTRICAS, ESPLENECTOMIA, FATORES DE RISCO, ESTUDOS RETROSPECTIVOS, TEMPO DE INTERNAÇÃO, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIAS, Andre R et al. Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma. Journal of surgical oncology, v. 121, n. 5, p. 840-847, 2020Tradução . . Disponível em: https://doi.org/10.1002/jso.25862. Acesso em: 18 nov. 2024.
APA
Dias, A. R., Pereira, M. A., Oliveira, R. J., Ramos, M. F. K. P., Szor, D. J., Ribeiro Junior, U., et al. (2020). Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma. Journal of surgical oncology, 121( 5), 840-847. doi:10.1002/jso.25862
NLM
Dias AR, Pereira MA, Oliveira RJ, Ramos MFKP, Szor DJ, Ribeiro Junior U, Zilberstein B, Cecconello I. Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 840-847.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25862
Vancouver
Dias AR, Pereira MA, Oliveira RJ, Ramos MFKP, Szor DJ, Ribeiro Junior U, Zilberstein B, Cecconello I. Multivisceral resection vs standard gastrectomy for gastric adenocarcinoma [Internet]. Journal of surgical oncology. 2020 ; 121( 5): 840-847.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/jso.25862

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects